RegistriesIncidenceRisk FactorsTreatment OutcomeUnited StatesRetrospective StudiesDenmarkTime FactorsCohort StudiesFollow-Up StudiesProspective StudiesNeoplasmsSEER ProgramRisk AssessmentAge FactorsSurvival RateAge DistributionHospital MortalityEuropeInfant, NewbornRare DiseasesSurvival AnalysisNorwayDatabases, FactualSwedenAngioplasty, Balloon, CoronaryMyocardial InfarctionPrognosisProportional Hazards ModelsPopulation SurveillanceLogistic ModelsMedical Record LinkageMultivariate AnalysisDrug-Eluting StentsSex FactorsKaplan-Meier EstimateSex DistributionPatient SelectionGermanyHospital RecordsOdds RatioFranceBreast NeoplasmsDiseases in TwinsItalyStrokeCause of DeathRiskChi-Square DistributionSpainStentsJapanAustraliaHospitalizationData CollectionMedical RecordsPrevalenceTwins, DizygoticCaliforniaComorbidityResearch DesignTwins, MonozygoticCongenital AbnormalitiesCase-Control StudiesOutcome Assessment (Health Care)Percutaneous Coronary InterventionDeath CertificatesCanadaSurvivorsQuestionnairesFinlandSeverity of Illness IndexCardiovascular AgentsProduct Surveillance, PostmarketingInternational CooperationAcute Coronary SyndromeNorth AmericaNetherlandsClinical CodingPregnancyConfidence IntervalsNeoplasm StagingSwitzerlandCoronary Artery DiseasePropensity ScorePostoperative ComplicationsPlatelet Aggregation InhibitorsEpidemiologic MethodsMichiganProsthesis DesignCoronary RestenosisRenal Replacement TherapyNew ZealandRecurrenceTissue DonorsTrauma CentersTissue and Organ ProcurementGuideline AdherencePredictive Value of TestsRegression Analysis